Progyny, Inc. (NASDAQ: PGNY) Stock Competitors & Peer Comparison
See PGNY's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PGNY and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PGNY | $31.93 | +0.22% | 2.5B | 23.31 | $1.37 | N/A |
| VEEV | $195.38 | -1.01% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $63.07 | -4.00% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $70.69 | +3.71% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $231.53 | +1.23% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $52.47 | -2.09% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.67 | +2.73% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $87.09 | +1.29% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
PGNY vs VEEV Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while VEEV trades at $195.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas VEEV's P/E ratio is 23.46. In terms of profitability, PGNY's ROE is +0.13%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, PGNY is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
PGNY vs GEHC Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while GEHC trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas GEHC's P/E ratio is 13.83. In terms of profitability, PGNY's ROE is +0.13%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, PGNY is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
PGNY vs GEHCV Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas GEHCV's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, PGNY is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
PGNY vs BTSG Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while BTSG trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas BTSG's P/E ratio is 57.01. In terms of profitability, PGNY's ROE is +0.13%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, PGNY is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
PGNY vs BTSGU Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while BTSGU trades at $231.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, PGNY's ROE is +0.13%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, PGNY is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
PGNY vs TEM Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while TEM trades at $52.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas TEM's P/E ratio is -104.94. In terms of profitability, PGNY's ROE is +0.13%, compared to TEM's ROE of -0.70%. Regarding short-term risk, PGNY is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
PGNY vs SGFY Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SGFY's P/E ratio is 70.91. In terms of profitability, PGNY's ROE is +0.13%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, PGNY is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
PGNY vs HQY Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while HQY trades at $97.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas HQY's P/E ratio is 23.06. In terms of profitability, PGNY's ROE is +0.13%, compared to HQY's ROE of +0.11%. Regarding short-term risk, PGNY is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
PGNY vs HNGE Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while HNGE trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas HNGE's P/E ratio is 44.66. In terms of profitability, PGNY's ROE is +0.13%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, PGNY is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
PGNY vs RCM Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas RCM's P/E ratio is -102.21. In terms of profitability, PGNY's ROE is +0.13%, compared to RCM's ROE of +0.00%. Regarding short-term risk, PGNY is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
PGNY vs TXG Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while TXG trades at $43.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas TXG's P/E ratio is -257.29. In terms of profitability, PGNY's ROE is +0.13%, compared to TXG's ROE of -0.03%. Regarding short-term risk, PGNY is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
PGNY vs DOCS Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while DOCS trades at $21.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas DOCS's P/E ratio is 14.07. In terms of profitability, PGNY's ROE is +0.13%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, PGNY is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
PGNY vs ONEM Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas ONEM's P/E ratio is -7.77. In terms of profitability, PGNY's ROE is +0.13%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, PGNY is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
PGNY vs PRVA Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while PRVA trades at $26.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas PRVA's P/E ratio is 168.13. In terms of profitability, PGNY's ROE is +0.13%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, PGNY is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check PRVA's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
PGNY vs HTFL Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while HTFL trades at $24.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas HTFL's P/E ratio is -12.92. In terms of profitability, PGNY's ROE is +0.13%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, PGNY is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
PGNY vs WGS Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while WGS trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas WGS's P/E ratio is 74.68. In terms of profitability, PGNY's ROE is +0.13%, compared to WGS's ROE of -0.28%. Regarding short-term risk, PGNY is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
PGNY vs TDOC Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while TDOC trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas TDOC's P/E ratio is -10.47. In terms of profitability, PGNY's ROE is +0.13%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, PGNY is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
PGNY vs NXGN Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas NXGN's P/E ratio is -266.00. In terms of profitability, PGNY's ROE is +0.13%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, PGNY is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
PGNY vs OMDA Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while OMDA trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas OMDA's P/E ratio is 338.57. In terms of profitability, PGNY's ROE is +0.13%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, PGNY is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
PGNY vs AGTI Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas AGTI's P/E ratio is -71.79. In terms of profitability, PGNY's ROE is +0.13%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, PGNY is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
PGNY vs GDRX Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while GDRX trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas GDRX's P/E ratio is 9.52. In terms of profitability, PGNY's ROE is +0.13%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, PGNY is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
PGNY vs CERT Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CERT trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CERT's P/E ratio is 17.77. In terms of profitability, PGNY's ROE is +0.13%, compared to CERT's ROE of -0.01%. Regarding short-term risk, PGNY is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
PGNY vs CCLDO Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CCLDO's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, PGNY is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
PGNY vs HSTM Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while HSTM trades at $28.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas HSTM's P/E ratio is 38.08. In terms of profitability, PGNY's ROE is +0.13%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, PGNY is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
PGNY vs WGSWW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, PGNY's ROE is +0.13%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, PGNY is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
PGNY vs PHR Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, PHR has a market cap of 662M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while PHR trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas PHR's P/E ratio is 38.25. In terms of profitability, PGNY's ROE is +0.13%, compared to PHR's ROE of +0.03%. Regarding short-term risk, PGNY is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
PGNY vs EVH Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while EVH trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas EVH's P/E ratio is 580.00. In terms of profitability, PGNY's ROE is +0.13%, compared to EVH's ROE of -0.78%. Regarding short-term risk, PGNY is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
PGNY vs MPLN-WT Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, PGNY is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
PGNY vs ACCD Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas ACCD's P/E ratio is -3.08. In terms of profitability, PGNY's ROE is +0.13%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, PGNY is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
PGNY vs SHCR Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SHCR's P/E ratio is -3.76. In terms of profitability, PGNY's ROE is +0.13%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, PGNY is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
PGNY vs CTEV Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CTEV trades at $30.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CTEV's P/E ratio is -2.33. In terms of profitability, PGNY's ROE is +0.13%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, PGNY is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
PGNY vs NRC Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while NRC trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas NRC's P/E ratio is 26.56. In terms of profitability, PGNY's ROE is +0.13%, compared to NRC's ROE of +0.57%. Regarding short-term risk, PGNY is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
PGNY vs SOPH Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SOPH trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SOPH's P/E ratio is -11.29. In terms of profitability, PGNY's ROE is +0.13%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, PGNY is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
PGNY vs SLGCW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, PGNY's ROE is +0.13%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, PGNY is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
PGNY vs SLGC Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SLGC's P/E ratio is -3.04. In terms of profitability, PGNY's ROE is +0.13%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, PGNY is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
PGNY vs TBRG Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas TBRG's P/E ratio is 9.37. In terms of profitability, PGNY's ROE is +0.13%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, PGNY is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
PGNY vs MPLN Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas MPLN's P/E ratio is -0.23. In terms of profitability, PGNY's ROE is +0.13%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, PGNY is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
PGNY vs SLP Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SLP's P/E ratio is 20.72. In terms of profitability, PGNY's ROE is +0.13%, compared to SLP's ROE of +0.06%. Regarding short-term risk, PGNY is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
PGNY vs TRHC Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas TRHC's P/E ratio is -4.27. In terms of profitability, PGNY's ROE is +0.13%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, PGNY is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
PGNY vs SMFR Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SMFR's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, PGNY is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
PGNY vs SPOK Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SPOK trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SPOK's P/E ratio is 17.73. In terms of profitability, PGNY's ROE is +0.13%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, PGNY is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
PGNY vs SY Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SY trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SY's P/E ratio is -5.09. In terms of profitability, PGNY's ROE is +0.13%, compared to SY's ROE of -0.16%. Regarding short-term risk, PGNY is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check SY's competition here
American Well Corporation (NYSE: AMWL)
PGNY vs AMWL Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while AMWL trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas AMWL's P/E ratio is -2.54. In terms of profitability, PGNY's ROE is +0.13%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, PGNY is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
PGNY vs HCAT Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while HCAT trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas HCAT's P/E ratio is 11.25. In terms of profitability, PGNY's ROE is +0.13%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, PGNY is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
PGNY vs CPSI Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CPSI's P/E ratio is -183.80. In terms of profitability, PGNY's ROE is +0.13%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, PGNY is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
PGNY vs OPRX Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while OPRX trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas OPRX's P/E ratio is 6.14. In terms of profitability, PGNY's ROE is +0.13%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, PGNY is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
PGNY vs AUGX Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas AUGX's P/E ratio is -4.99. In terms of profitability, PGNY's ROE is +0.13%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, PGNY is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
PGNY vs CCLD Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CCLD trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CCLD's P/E ratio is 8.59. In terms of profitability, PGNY's ROE is +0.13%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, PGNY is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
PGNY vs DH Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while DH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas DH's P/E ratio is 2.92. In terms of profitability, PGNY's ROE is +0.13%, compared to DH's ROE of -0.67%. Regarding short-term risk, PGNY is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
PGNY vs FORA Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas FORA's P/E ratio is -24.11. In terms of profitability, PGNY's ROE is +0.13%, compared to FORA's ROE of -0.17%. Regarding short-term risk, PGNY is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
PGNY vs CCLDP Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CCLDP's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, PGNY is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
PGNY vs ONMD Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while ONMD trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas ONMD's P/E ratio is -4.53. In terms of profitability, PGNY's ROE is +0.13%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, PGNY is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
PGNY vs SNCE Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SNCE's P/E ratio is -0.27. In terms of profitability, PGNY's ROE is +0.13%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, PGNY is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
PGNY vs AKLI Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas AKLI's P/E ratio is -0.71. In terms of profitability, PGNY's ROE is +0.13%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, PGNY is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
PGNY vs SHLT Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SHLT's P/E ratio is -3.87. In terms of profitability, PGNY's ROE is +0.13%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, PGNY is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
PGNY vs SHCRW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, PGNY's ROE is +0.13%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, PGNY is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
PGNY vs ONMDW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas ONMDW's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, PGNY is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
PGNY vs STRM Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas STRM's P/E ratio is -2.40. In terms of profitability, PGNY's ROE is +0.13%, compared to STRM's ROE of -0.32%. Regarding short-term risk, PGNY is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
PGNY vs RNLX Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas RNLX's P/E ratio is -0.33. In terms of profitability, PGNY's ROE is +0.13%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, PGNY is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
PGNY vs LIFW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas LIFW's P/E ratio is -0.02. In terms of profitability, PGNY's ROE is +0.13%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, PGNY is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
PGNY vs EUDA Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while EUDA trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas EUDA's P/E ratio is -21.32. In terms of profitability, PGNY's ROE is +0.13%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, PGNY is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
PGNY vs BBLN Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas BBLN's P/E ratio is -0.04. In terms of profitability, PGNY's ROE is +0.13%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, PGNY is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
PGNY vs BEATW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas BEATW's P/E ratio is -0.04. In terms of profitability, PGNY's ROE is +0.13%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, PGNY is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
PGNY vs ETAO Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas ETAO's P/E ratio is -0.01. In terms of profitability, PGNY's ROE is +0.13%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, PGNY is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
PGNY vs BFRG Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while BFRG trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas BFRG's P/E ratio is -1.20. In terms of profitability, PGNY's ROE is +0.13%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, PGNY is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
PGNY vs HLTH Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas HLTH's P/E ratio is -0.02. In terms of profitability, PGNY's ROE is +0.13%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, PGNY is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
PGNY vs SCNX Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas SCNX's P/E ratio is -0.16. In terms of profitability, PGNY's ROE is +0.13%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, PGNY is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
PGNY vs UPH Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas UPH's P/E ratio is -0.07. In terms of profitability, PGNY's ROE is +0.13%, compared to UPH's ROE of -1.05%. Regarding short-term risk, PGNY is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
PGNY vs UPH-WT Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, PGNY is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
PGNY vs MGRX Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while MGRX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas MGRX's P/E ratio is -0.31. In terms of profitability, PGNY's ROE is +0.13%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, PGNY is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
PGNY vs PEAR Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas PEAR's P/E ratio is -0.08. In terms of profitability, PGNY's ROE is +0.13%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, PGNY is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
PGNY vs PEARW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas PEARW's P/E ratio is -0.00. In terms of profitability, PGNY's ROE is +0.13%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, PGNY is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
PGNY vs OTRK Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas OTRK's P/E ratio is -0.02. In terms of profitability, PGNY's ROE is +0.13%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, PGNY is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
PGNY vs VSEEW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, PGNY's ROE is +0.13%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, PGNY is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
PGNY vs HCTI Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while HCTI trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas HCTI's P/E ratio is -0.23. In terms of profitability, PGNY's ROE is +0.13%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, PGNY is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
PGNY vs CMAX Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CMAX's P/E ratio is -0.00. In terms of profitability, PGNY's ROE is +0.13%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, PGNY is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
PGNY vs VSEE Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas VSEE's P/E ratio is -0.19. In terms of profitability, PGNY's ROE is +0.13%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, PGNY is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
PGNY vs ACON Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while ACON trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas ACON's P/E ratio is -0.24. In terms of profitability, PGNY's ROE is +0.13%, compared to ACON's ROE of -0.54%. Regarding short-term risk, PGNY is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
PGNY vs LIFWZ Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, PGNY is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
PGNY vs EUDAW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, PGNY's ROE is +0.13%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, PGNY is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
PGNY vs WORX Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas WORX's P/E ratio is -0.76. In terms of profitability, PGNY's ROE is +0.13%, compared to WORX's ROE of -0.65%. Regarding short-term risk, PGNY is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
PGNY vs MSPRZ Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, PGNY is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
PGNY vs KERN Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas KERN's P/E ratio is -0.01. In terms of profitability, PGNY's ROE is +0.13%, compared to KERN's ROE of -0.17%. Regarding short-term risk, PGNY is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
PGNY vs KERNW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas KERNW's P/E ratio is -0.00. In terms of profitability, PGNY's ROE is +0.13%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, PGNY is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
PGNY vs LIFWW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas LIFWW's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, PGNY is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
PGNY vs ZCMD Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while ZCMD trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, PGNY's ROE is +0.13%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, PGNY is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
PGNY vs CMAXW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CMAXW's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, PGNY is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
PGNY vs ACONW Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas ACONW's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, PGNY is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
PGNY vs MTBCO Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas MTBCO's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, PGNY is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
PGNY vs MSPRV Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas MSPRV's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to MSPRV's ROE of N/A. Regarding short-term risk, PGNY is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
PGNY vs MTBCP Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas MTBCP's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, PGNY is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
PGNY vs MTBC Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas MTBC's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, PGNY is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
PGNY vs CHNG Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CHNG's P/E ratio is -152.72. In terms of profitability, PGNY's ROE is +0.13%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, PGNY is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
PGNY vs CHNGU Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CHNGU's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, PGNY is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
PGNY vs CNVY Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CNVY's P/E ratio is -71.50. In terms of profitability, PGNY's ROE is +0.13%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, PGNY is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
PGNY vs NAVA Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas NAVA's P/E ratio is N/A. In terms of profitability, PGNY's ROE is +0.13%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, PGNY is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for PGNY.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
PGNY vs CERN Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CERN has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CERN's P/E ratio is 55.84. In terms of profitability, PGNY's ROE is +0.13%, compared to CERN's ROE of +0.14%. Regarding short-term risk, PGNY is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
PGNY vs CSLT Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas CSLT's P/E ratio is -37.27. In terms of profitability, PGNY's ROE is +0.13%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, PGNY is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for PGNY.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
PGNY vs NH Comparison July 2026
Progyny, Inc. (NASDAQ: PGNY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGNY stands at 2.5B. In comparison, NH has a market cap of 0. Regarding current trading prices, PGNY is priced at $31.93 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGNY currently has a P/E ratio of 23.31, whereas NH's P/E ratio is -0.12. In terms of profitability, PGNY's ROE is +0.13%, compared to NH's ROE of +0.35%. Regarding short-term risk, PGNY is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for PGNY.Check NH's competition here